Pacira Pharmaceuticals Stock Forecast
Pacira Pharmaceuticals stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 10, 2024)
The Pacira Pharmaceuticals stock price fell by -1.47% on the last day (Friday, 10th May 2024) from $29.86 to $29.42. During the last trading day the stock fluctuated 5.25% from a day low at $29.14 to a day high of $30.67. The price has risen in 6 of the last 10 days and is up by 11.74% over the past 2 weeks. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $164.25 million.
The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $29.80 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -10.94% during the next 3 months and, with a 90% probability hold a price between $22.13 and $26.54 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PCRX Signals & Forecast
The Pacira Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.07 and $27.59. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 09, 2024, and so far it has fallen -1.47%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Pacira Pharmaceuticals stock
Pacira Pharmaceuticals finds support from accumulated volume at $29.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.53 between high and low, or 5.25%. For the last week, the stock has had daily average volatility of 5.45%.
Our recommended stop-loss: $28.48 (-3.20%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (PCRX) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect Pacira Pharmaceuticals to open at $29.74, and during the day (based on 14 day Average True Range), to move between $28.25 and $30.59, which gives a possible trading interval of +/-$1.17 (+/-3.97%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 7.94% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $29.41 (0.03%) than the resistance at $29.65 (0.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Pacira Pharmaceuticals stock A Buy?
Pacira Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
Current score: -0.545 Hold/Accumulate Downgraded
Predicted Opening Price for Pacira Pharmaceuticals of Monday, May 13, 2024
| Fair opening price May 13, 2024 | Current price |
|---|---|
| $29.74 ( 1.10%) | $29.42 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PCRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 31.27 | 6.30 % | |
| R2 | 30.69 | 4.31 % | ||
| R1 | 30.33 | 3.09 % | ||
| Current price: | 29.42 | |||
| Support | S1 | 29.16 | -0.89 % | |
| S2 | 28.80 | -2.11 % | ||
| S3 | 28.21 | -4.10 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 30.02 | 2.04 % | |
| R2 | 29.86 | 1.50 % | ||
| R1 | 29.65 | 0.782 % | ||
| Current price | 29.42 | |||
| Support | S1 | 29.41 | -0.0340% | |
| S2 | 28.51 | -3.09% | ||
| S3 | 26.10 | -11.28% |
FAQ
Click here for our free guide on how to buy Pacira Pharmaceuticals Stock.
